Navigation Links
Ontak in Medical Technology

FDA Files Application To Convert ONTAK(R) (Denileukin Diftitox) to Full Approval for Use in Cutaneous T-Cell Lymphoma (CTCL)

...cal trial to confirm the clinical effectiveness of ontak in certain patients with cutaneous T-cell lymphoma (CTCL). ontak is indicated for the treatment of patients with pe...t of the IL-2 receptor. The safety and efficacy of ontak in patients with CTCL whose malignant cells do not...

Ontak (denileukin diftitox) Achieves 49.1% Overall Response Rate in Phase III Trial of Cutaneous T-Cell Lymphoma (CTCL)

... with cutaneous T-cell lymphoma (CTCL) showed that ontak was more than twice as effective as placebo in eli...American Society of Clinical Oncology (ASCO). ontak is indicated for the treatment of patients with pe...onent of the IL-2 receptor have not been examined. ontak was granted accelerated approval in February 1999....
Ontak in other areas

Ontak (Denileukin Diftitox) Drug Information: Uses, Side Effects, Drug ...

Learn about the prescription medication Ontak (Denileukin Diftitox), drug uses, dosage, side effects, drug interactions, warnings, and patient labeling.

ONTAK

ONTAK is supplied in single use vials as a sterile, frozen solution intended for ... Each 2 mL vial of ONTAK contains 300 mcg of ...

Ontak, Denileukin Diftitox - Chemotherapy Drugs, Chemo Drug Side Effects

Ontak is the trade name for Denileukin Diftitox. Ontak is a targeted therapy. ... professionals may use the trade name Ontak when referring to the generic drug ...

FDA Files Application To Convert ONTAK(R) (Denileukin Diftitox) To Full ...

... priority review a supplemental biologics license application (sBLA) for ONTAK(R) ... ONTAK is indicated for the treatment of patients with persistent or recurrent ...

ONTAK(R) (denileukin Diftitox) Achieves 49.1% Overall Response Rate In ...

Preliminary results of the largest randomized, placebo-controlled clinical trial ever conducted in patients with cutaneous T-cell lymphoma (CTCL) showed that ONTAK ...

Success Story: Ontak (NSC 697979)

1998 Ontak (NSC 697979), also known as denileukin diftitox or interleukin-2 (IL ... Ontak is one of four NCDDG-developed agents approved by the FDA since the ...
Other Tags
(Date:12/19/2014)... Slone Partners , a ... healthcare information technology, and laboratory testing industries, has ... Operating Officer. The announcement comes after a year ... strengthened presence in Boston and several new additions ... breathes the client experience," said Adam Slone, Chief ...
(Date:12/19/2014)... Irving, Texas (PRWEB) December 19, 2014 ... recently exhibited at the AMSUS Society for Federal ... represent the locum tenens industry to military and ... Staffing attended the National Veterans Small Business Engagement ... “Locum Tenens continues to be a vital solution ...
(Date:12/19/2014)... (HealthDay News) -- A new study suggests a possible ... hot flashes and night sweats -- and higher rates ... are common during menopause, affecting about 60 percent of ... after menopause, since they then face a higher risk ... women who exhibit moderate or severe menopausal symptoms are ...
(Date:12/19/2014)... Randy Dotinga ... News) -- Common painkillers, including ibuprofen, might slightly reduce ... researchers say. Use of ibuprofen (Advil, Motrin) and ... cell skin cancer by 15 percent, the researchers concluded ... is usually caused by sun exposure. ...
(Date:12/19/2014)... HealthDay Reporter THURSDAY, Dec. 18, 2014 (HealthDay ... at least 20 seconds you may be at risk of ... leg may indicate that small strokes or tiny bleeds have ... is high, the investigators reported online Dec. 18 in the ... on one leg, as well as problems walking, should receive ...
Breaking Medicine News(10 mins):Health News:Slone Partners Promotes Leslie Loveless to Chief Operating Officer 2Health News:Consilium Staffing Increasing Awareness of Locum Tenens through Conference Appearances 2Health News:Severe Hot Flashes During Menopause May Raise Hip Fracture Risk Later: Study 2Health News:Common Painkillers May Help Prevent Certain Skin Cancers, Study Finds 2Health News:Common Painkillers May Help Prevent Certain Skin Cancers, Study Finds 3Health News:Can You Balance on One Leg? You May Have Lower Stroke Risk 2
(Date:12/15/2014)... --Research and Markets ( http://www.researchandmarkets.com/research/87pph8/global_facial ) ... Facial Recognition Market 2015-2019" report to their ... Facial recognition is a technology used ... measures the overall facial feature of a person ... distance between eyes. Facial recognition is used for ...
(Date:12/11/2014)... Minn. , Dec. 10, 2014  Data ... physiologic monitoring, has released a new series of ... of preclinical toxicology researchers. M series, part of ... toxicologists collect the best possible physiologic data when ... Adding functional endpoints to toxicology studies has ...
(Date:12/10/2014)... DIEGO , Dec. 9, 2014 CIE ... collaboration catalyst that provides the connective tissue that enhances ... enabling them to easily share client-level information; earned a ... to expand to organizations serving seniors aging in community ... Diego" partner on December 11 th 4-6p. ...
Breaking Biology News(10 mins):Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3New telemetry implants expected to change how large animal toxicology studies are conducted 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 3Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 4
Other Contents